| Mr Lacey Broom Holmes, LCSW | |
|
1312c Harrison Ave, Mccomb, MS 39648-2830 | |
| (601) 684-8284 | |
| Not Available |
| Full Name | Mr Lacey Broom Holmes |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 17 Years |
| Location | 1312c Harrison Ave, Mccomb, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821560319 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | C5152 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Serenity Psychiatric Outpatient, Llc | 7911181805 | 7 |
News Archive
Semafore Pharmaceuticals today announced the presentation of preliminary clinical data demonstrating that SF1126 has clinical activity in chronic lymphocytic leukemia (CLL). SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). The results were presented at Cambridge Healthtech Institute's 8th Annual Next-Gen Kinase Inhibitors Oncology & Beyond Conference being held June 21-23, 2010, in Cambridge, Massachusetts.
Improving the quality and coverage of nutritional advice given to families in developing countries could reduce the incidence of stunted growth in infants, suggests a study published online today by The Lancet.
A new systematic review and meta-analysis focused on the humoral and cell-mediated immune responses after COVID-19 vaccination in patients undergoing anti-CD20 antibodies treatment.
The Cancer Center at Beth Israel Deaconess Medical Center today announced the launch of a new clinical and research institute that will build on BIDMC's long history of leadership in immunotherapy and cell therapeutics.
› Verified 2 days ago
| Entity Name | Serenity Psychiatric Outpatient, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881973642 PECOS PAC ID: 7911181805 Enrollment ID: O20110914000274 |
News Archive
Semafore Pharmaceuticals today announced the presentation of preliminary clinical data demonstrating that SF1126 has clinical activity in chronic lymphocytic leukemia (CLL). SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). The results were presented at Cambridge Healthtech Institute's 8th Annual Next-Gen Kinase Inhibitors Oncology & Beyond Conference being held June 21-23, 2010, in Cambridge, Massachusetts.
Improving the quality and coverage of nutritional advice given to families in developing countries could reduce the incidence of stunted growth in infants, suggests a study published online today by The Lancet.
A new systematic review and meta-analysis focused on the humoral and cell-mediated immune responses after COVID-19 vaccination in patients undergoing anti-CD20 antibodies treatment.
The Cancer Center at Beth Israel Deaconess Medical Center today announced the launch of a new clinical and research institute that will build on BIDMC's long history of leadership in immunotherapy and cell therapeutics.
› Verified 2 days ago
| Entity Name | Hope For Healing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982335386 PECOS PAC ID: 1850752619 Enrollment ID: O20230727000211 |
News Archive
Semafore Pharmaceuticals today announced the presentation of preliminary clinical data demonstrating that SF1126 has clinical activity in chronic lymphocytic leukemia (CLL). SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). The results were presented at Cambridge Healthtech Institute's 8th Annual Next-Gen Kinase Inhibitors Oncology & Beyond Conference being held June 21-23, 2010, in Cambridge, Massachusetts.
Improving the quality and coverage of nutritional advice given to families in developing countries could reduce the incidence of stunted growth in infants, suggests a study published online today by The Lancet.
A new systematic review and meta-analysis focused on the humoral and cell-mediated immune responses after COVID-19 vaccination in patients undergoing anti-CD20 antibodies treatment.
The Cancer Center at Beth Israel Deaconess Medical Center today announced the launch of a new clinical and research institute that will build on BIDMC's long history of leadership in immunotherapy and cell therapeutics.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Lacey Broom Holmes, LCSW 18 Atley Holmes Rd, Jayess, MS 39641-8272 Ph: (601) 303-0154 | Mr Lacey Broom Holmes, LCSW 1312c Harrison Ave, Mccomb, MS 39648-2830 Ph: (601) 684-8284 |
News Archive
Semafore Pharmaceuticals today announced the presentation of preliminary clinical data demonstrating that SF1126 has clinical activity in chronic lymphocytic leukemia (CLL). SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). The results were presented at Cambridge Healthtech Institute's 8th Annual Next-Gen Kinase Inhibitors Oncology & Beyond Conference being held June 21-23, 2010, in Cambridge, Massachusetts.
Improving the quality and coverage of nutritional advice given to families in developing countries could reduce the incidence of stunted growth in infants, suggests a study published online today by The Lancet.
A new systematic review and meta-analysis focused on the humoral and cell-mediated immune responses after COVID-19 vaccination in patients undergoing anti-CD20 antibodies treatment.
The Cancer Center at Beth Israel Deaconess Medical Center today announced the launch of a new clinical and research institute that will build on BIDMC's long history of leadership in immunotherapy and cell therapeutics.
› Verified 2 days ago
Bente Johnson, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1301b Harrison Ave, Mccomb, MS 39648 Phone: 601-600-2429 Fax: 601-600-2428 | |
Kelsa Thames, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 300 Rawls Dr, Mccomb, MS 39648 Phone: 601-684-8284 Fax: 601-684-8199 | |
Mrs. Tracey Michele Alexander-boyd, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1701 White St, Mccomb, MS 39648 Phone: 601-684-2173 Fax: 601-249-4234 | |
Pamela J Spiers-jones, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1701 White St, Mccomb, MS 39648 Phone: 601-684-2173 Fax: 601-249-4234 | |
Mr. Roger Darren Price, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1701 White St, Mccomb, MS 39648 Phone: 601-684-2173 Fax: 601-249-4234 | |
Jane C Funderburg, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1701 White St, Mccomb, MS 39648 Phone: 601-249-4219 Fax: 601-249-4234 | |
Jessie L Singleton, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1701 White Street, Mccomb, MS 39648 Phone: 601-249-4217 Fax: 601-249-4234 |